110 related articles for article (PubMed ID: 37942626)
1. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition.
Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
[TBL] [Abstract][Full Text] [Related]
2. Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system.
Cheng Y; Sun R; He M; Zhang M; Hou X; Sun Y; Wang J; Xu J; He H; Wang H; Lan M; Zhao Y; Yang Y; Chen X; Gao F
Int J Pharm; 2022 Apr; 618():121613. PubMed ID: 35217071
[TBL] [Abstract][Full Text] [Related]
3. An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition.
Wang K; Ye H; Zhang X; Wang X; Yang B; Luo C; Zhao Z; Zhao J; Lu Q; Zhang H; Kan Q; Wang Y; He Z; Sun J
Biomaterials; 2020 Oct; 257():120224. PubMed ID: 32736255
[TBL] [Abstract][Full Text] [Related]
4. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
[TBL] [Abstract][Full Text] [Related]
5. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
[TBL] [Abstract][Full Text] [Related]
6. A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy.
Hou X; Shou C; He M; Xu J; Cheng Y; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F
Acta Pharm Sin B; 2020 Sep; 10(9):1741-1753. PubMed ID: 33088693
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy.
He M; Wang Y; Chen X; Zhao Y; Lou K; Wang Y; Huang L; Hou X; Xu J; Cai X; Cheng Y; Lan M; Yang Y; Gao F
J Control Release; 2020 Mar; 319():1-14. PubMed ID: 31838205
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy.
Cheng Y; Zou J; He M; Hou X; Wang H; Xu J; Yuan Z; Lan M; Yang Y; Chen X; Gao F
J Control Release; 2024 Mar; 367():167-183. PubMed ID: 37562556
[TBL] [Abstract][Full Text] [Related]
10. Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology.
Xu J; He M; Hou X; Wang Y; Shou C; Cai X; Yuan Z; Yin Y; Lan M; Lou K; Zhao Y; Yang Y; Chen X; Gao F
Mol Pharm; 2020 Jan; 17(1):301-315. PubMed ID: 31765570
[TBL] [Abstract][Full Text] [Related]
11. The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer.
Zhang W; Xia L; Ren X; Cui M; Liu T; Ling C; Xu Y; Deng D; Zhang X; Gu Y; Wang P
Biomater Sci; 2020 Nov; 8(21):5941-5954. PubMed ID: 32966407
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy.
He M; Sun Y; Cheng Y; Wang J; Zhang M; Sun R; Hou X; Xu J; He H; Wang H; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F
J Control Release; 2023 Mar; 355():538-551. PubMed ID: 36063962
[TBL] [Abstract][Full Text] [Related]
13. An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis.
Meng X; Wang M; Zhang K; Sui D; Chen M; Xu Z; Guo T; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2022 Oct; 23(8):285. PubMed ID: 36258152
[TBL] [Abstract][Full Text] [Related]
14. Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple-Negative Breast Cancer.
Cao Y; Ge X; Zhu X; Han Y; Wang P; Akakuru OU; Wu A; Li J
Adv Sci (Weinh); 2023 Jul; 10(21):e2300545. PubMed ID: 37147783
[TBL] [Abstract][Full Text] [Related]
15. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
[TBL] [Abstract][Full Text] [Related]
16. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
[TBL] [Abstract][Full Text] [Related]
17. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
[TBL] [Abstract][Full Text] [Related]
18. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy.
Fan Y; Wang Q; Lin G; Shi Y; Gu Z; Ding T
Acta Biomater; 2017 Oct; 62():257-272. PubMed ID: 28859899
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a novel, sequentially active-targeted drug delivery nanoplatform for breast cancer therapy.
Satsangi A; Roy SS; Satsangi RK; Tolcher AW; Vadlamudi RK; Goins B; Ong JL
Biomaterials; 2015 Aug; 59():88-101. PubMed ID: 25956854
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment.
Salmaso S; Mastrotto F; Roverso M; Gandin V; De Martin S; Gabbia D; De Franco M; Vaccarin C; Verona M; Chilin A; Caliceti P; Bogialli S; Marzaro G
J Control Release; 2021 Dec; 340():318-330. PubMed ID: 34748872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
